Annovis Bio, Inc. (ANVS)

5,56 -0,53 (-8,70%) Börsenschluss: 04:00PM EDT

Annovis Bio, Inc.

101 Lindenwood Drive
Suite 225
Malvern, PA 19355
United States
(484) 875-3192
https://www.annovisbio.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 6

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Maria L. Maccecchini Ph.D.	Founder, CEO, President, Interim Principal Financial Officer & Executive Director	681,2k	N/A	1951
Dr. Cheng Fang Ph.D.	Senior Vice President of Research & Development	N/A	N/A	N/A
Ms. Eve M. Damiano M.S., RAC	Senior Vice President of Regulatory Operations	N/A	N/A	N/A
Ms. Melissa Gaines	Senior Vice President of Clinical Operations	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.

Corporate Governance

Annovis Bio, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.